Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review)
International Journal of Molecular Medicine · 2023
DOI: 10.3892/ijmm.2023.5253 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift International Journal of Molecular Medicine, 2023. Verfasst von Zhenwang Ma und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Encephalopathy, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, Heilongjiang 150036, P.R. China. Hauptthemen laut MEDLINE: Parkinson Disease, MicroRNAs. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 115 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Parkinson's disease (PD) is a neurodegenerative disorder that has a high incidence during the aging process and is characterized by the loss of dopaminergic neurons in the substantia nigra, leading to motor dysfunctions and non‑motor symptoms. Impaired clearance and excessive accumulation of aberrantly modified proteins or damaged organelles, such as aggregated α‑synuclein and dysfunctional mitochondria, are regarded as the main causes of nigrostriatal neurodegeneration. As one of the major degradation pathways, autophagy can recycle these useless or toxic substances to maintain cellular homeostasis and it plays a crucial role in PD progression. MicroRNAs (miRNAs) are a group of small non‑coding RNA molecules that regulate gene expression by silencing targeted mRNAs. Recent studies have illustrated that autophagy‑regulating miRNA has been implicated in pathological processes of PD, including α‑synuclein accumulation, mitochondrial damage, neuroinflammation and neuronal apoptosis, which suggests that targeting autophagy‑regulating miRNAs may provide novel therapeutic strategies for this disease. The present review summarizes the role of autophagy in PD and emphasizes the role of miRNA‑mediated autophagy in PD, for the development of promising interventions in this disease.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Encephalopathy, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, Heilongjiang 150036, P.R. China.
- Graduate School of Heilongjiang University of Chinese Medicine, Harbin, Heilongjiang 150040, P.R. China.
- Department of Endocrinology, Heilongjiang Academy of Traditional Chinese Medicine, Harbin, Heilongjiang 150036, P.R. China.
Zitieren
APA
Ma, Z., Liang, H., Hu, B., Cai, S., & Yan, D. (2023). Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review). International Journal of Molecular Medicine. https://doi.org/10.3892/ijmm.2023.5253
Vancouver
Ma Z, Liang H, Hu B, Cai S, Yan D. Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review). International Journal of Molecular Medicine. 2023. doi:10.3892/ijmm.2023.5253
BibTeX
@article{Ma2023,
author = {Ma, Zhenwang and Liang, Hao and Hu, Bingcheng and Cai, Shaojie and Yan, Dong},
title = {Autophagy‑regulating miRNAs: Novel therapeutic targets for Parkinson's disease (Review)},
journal = {International Journal of Molecular Medicine},
year = {2023},
doi = {10.3892/ijmm.2023.5253}
}
EUVIMED